Login / Signup

A phase II Japanese trial of 90-minute rituximab infusion for untreated B-cell lymphoma.

Toko SaitoHirokazu NagaiKoji IzutsuKiyoshi AndoTadahiko IgarashiTohru IzumiYasuo OhashiShuhei KamiyamaKenichi IshizawaKensei Tobinai
Published in: Japanese journal of clinical oncology (2024)
JapicCTI-173 663.
Keyphrases
  • phase ii
  • diffuse large b cell lymphoma
  • clinical trial
  • open label
  • phase iii
  • low dose
  • placebo controlled
  • double blind
  • hodgkin lymphoma
  • chronic lymphocytic leukemia
  • study protocol
  • randomized controlled trial